Senior insider sale
Chief Financial Officer at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$22.4K
1.18K shares
What this filing means
GOLDAN KEITH A. plans to sell 1.18K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $22.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001959173-26-004218
Officer· Chief Financial Officer
Since Jun 2022
1.18K
Shares to sell
$22.4K
Approx. market value
1.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/29/2026
1.18KTotal acquired1.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/29/2026 | Restricted Stock Vesting Compensation | 1.18K | — |
| Total | 1.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.18K
Market value
$22.4K
6/1/2026
Total
Units
1.18K
Value
$22.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/1/2026 | 1.18K | $22.4K | NASDAQ | Planned |
| Total | 1.18K | $22.4K | ||